The Technical Analyst
Arcadia Biosciences Inc [RKDA]
Exchange: NASDAQ Sector: Basic Materials Industry: Agricultural Inputs
Arcadia Biosciences Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.41% $1.950
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2.66 mill |
| EPS: | -10.64 |
| P/E: | -0.180 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 1.363 mill |
| Avg Daily Volume: | 0.0199 mill |
| RATING 2024-04-18 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.180 | sector: PE -48.27 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.180 | industry: PE -5.53 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.802 - 2.10 ( +/- 7.59%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-02-01 | Schaefer Thomas J. | Buy | 700 | Common Stock |
| 2023-08-04 | Schaefer Thomas J. | Buy | 649 | Common Stock |
| 2023-06-06 | Carosella Deborah D | Buy | 937 | Stock Option (Right to Buy) |
| 2023-06-06 | Yoder Amy | Buy | 937 | Stock Option (Right to Buy) |
| 2023-06-06 | Bolles Albert D. | Buy | 937 | Stock Option (Right to Buy) |
| INSIDER POWER |
|---|
| 76.44 |
| Last 96 transactions |
| Buy: 1 770 423 | Sell: 83 782 |
Forecast:
16:00 - $1.950
Live Trading Signals (every 1 min)
Forecast
1: 15:54 - $1.960
Forecast 2: 16:00 - $1.950
Forecast 3: 16:00 - $1.950
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.950 (-4.41% ) |
| Volume | 0.0173 mill |
| Avg. Vol. | 0.0199 mill |
| % of Avg. Vol | 87.22 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RKDA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RKDA
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Last 10 Buy Signals
Latest Press Releases
2024-03-28 16:05:00 - Press Release
Arcadia Biosciences (rkda) Announces Fourth-quarter And Full-year 2023 Financial Results And Business Highlights
Dallas--(business wire)--arcadia biosciences, inc.® (nasdaq: rkda), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023. “we are now at the halfway point of project greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability, and the results of this focus are unmistakable,” said stan jacot, president and ceo. “arcadia has.
2024-03-14 08:02:00 - Press Release
Arcadia Biosciences (rkda) Announces Date Of Fourth Quarter 2023 Financial Results And Business Highlights Conference Call
Dallas--(business wire)--arcadia biosciences inc. (rkda) will announce its fourth quarter and full year 2023 financial results on march 28, 2024 at 4:30pm et.
2024-02-20 08:02:00 - Press Release
Arcadia Biosciences (rkda) Expands Goodwheat™ Mac & Cheese With Nationwide Availability
Dallas--(business wire)--arcadia biosciences, inc.® (nasdaq: rkda), a producer and marketer of innovative, plant-based health and wellness products, has expanded the availability of its better-for-you, high fiber goodwheat™ mac & cheese, making the sneaky delicious product available to consumers nationwide on amazon. made with noodles crafted from arcadia's proprietary wheat grain, which is naturally higher in fiber and protein than traditional wheat, goodwheat mac & cheese delivers the.
2023-11-09 16:05:00 - Press Release
Arcadia Biosciences (rkda) Announces Strong Third Quarter 2023 Financial Results And Business Highlights
Dallas--(business wire)--arcadia biosciences, inc.® (nasdaq: rkda), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2023. “arcadia continues to make excellent progress in executing project greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability,” said stan jacot, president and ceo. “goodwheattm pasta and pancake mixes and zola® cocon.
2023-10-26 08:02:00 - Press Release
Arcadia Biosciences (rkda) Announces Date Of Third Quarter 2023 Financial Results And Business Highlights Conference Call
Dallas--(business wire)--arcadia biosciences, inc.® (nasdaq: rkda), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2023 after market close on november 9, 2023. the company has scheduled a conference call for 4:30 p.m. eastern time (1:30 p.m. pacific time) to discuss third-quarter results and key strategic achievements. interested participants can join the conference.
Latest News
2024-04-01 12:26:04 - Zacks Investment Research
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
2024-03-28 21:12:08 - Seeking Alpha
Arcadia Biosciences, Inc. (RKDA) Q4 2023 Earnings Call Transcript
2024-03-28 20:26:03 - Zacks Investment Research
Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates
Arcadia Biosciences (RKDA) came out with a quarterly loss of $2.48 per share versus the Zacks Consensus Estimate of a loss of $2.68. This compares to loss of $6.31 per share a year ago.
2024-02-15 12:01:07 - Zacks Investment Research
5 Agriculture - Products Stocks to Watch in a Challenging Industry
The Zacks Rank for the Agriculture - Products industry paints a gloomy picture. Investors should keep an eye on these five stocks braving the industry headwinds -- West Fraser (WFG), CalMaine Foods (CALM), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA).
2023-11-27 12:47:40 - Zacks Investment Research
3 Agriculture - Products Stocks to Watch in a Promising Industry
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
2023-11-10 04:45:02 - Seeking Alpha
Arcadia Biosciences, Inc. (RKDA) Q3 2023 Earnings Call Transcript
Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants T.J. Schaefer - Chief Financial Officer Stan Jacot - President and Chief Executive Officer Conference Call Participants Dipesh Patel - H.C.
2023-10-26 08:02:00 - Business Wire
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2023 Financial Results and Business Highlights Conference Call
DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2023 after market close on November 9, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference.
2023-10-25 08:16:26 - Zacks Investment Research
New Strong Buy Stocks for October 25th
RKDA, GHRS, GPS, RITM and EXAI have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2023.
2023-10-17 08:16:17 - Zacks Investment Research
New Strong Buy Stocks for October 17th
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.
2023-09-05 08:02:00 - Business Wire
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and T.J. Schaefer, CFO, will be participating in two investor conferences during the month of September. H.C. Wainwright 25th Annual Global Investment Conference. Arcadia will be featured as a presenting company at the conference, to be held September 11-13, 2023 at the Lotte Palace Hotel in.